Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elotuzumab with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01478048Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2011
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of elotuzumab in multiple myeloma (MM), sponsored by Bristol Myers Squibb. Started Nov 2011; status: completed.
02
Drugs
elotuzumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01478048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478048.